Sensei Biotherapeutics, Inc. · NASDAQ:SNSE
Millennium Management LLC bought 12,180 and sold 2,741 Sensei Biotherapeutics, Inc. shares (Form 4)
Traded Mar 31 to Apr 1, 2026 · Filed May 15, 2026
From Mar 31 to Apr 1, 2026, Millennium Management LLC (10% owner) bought 12,180 and sold 2,741 Sensei Biotherapeutics, Inc. shares, leaving 147,731 shares. Filed May 15, 2026 (Form 4).
- Bought
- 12,180 shares (US$382K at an average US$31.37)
- Sold
- 2,741 shares (US$76,951 at an average US$28.07)
- Holding after
- 147,731 shares (held indirectly)
- Trading plan
- No
- Role
- 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Mar 31, 2026 | Common Stock | Buy | 616 | US$24.69 | 146,657 | Indirect |
| Mar 31, 2026 | Common Stock | Buy | 1,770 | US$25.32 | 146,657 | Indirect |
| Mar 31, 2026 | Common Stock | Buy | 1,048 | US$26.73 | 146,657 | Indirect |
| Mar 31, 2026 | Common Stock | Buy | 17 | US$27.78 | 146,657 | Indirect |
| Mar 31, 2026 | Common Stock | Buy | 186 | US$30.48 | 146,657 | Indirect |
| Mar 31, 2026 | Common Stock | Buy | 1,957 | US$31.45 | 146,657 | Indirect |
| Mar 31, 2026 | Common Stock | Buy | 411 | US$32.60 | 146,657 | Indirect |
| Mar 31, 2026 | Common Stock | Sale | 191 | US$24.28 | 146,657 | Indirect |
| Mar 31, 2026 | Common Stock | Sale | 1,251 | US$25.17 | 146,657 | Indirect |
| Mar 31, 2026 | Common Stock | Sale | 57 | US$27.11 | 146,657 | Indirect |
| Mar 31, 2026 | Common Stock | Sale | 5 | US$28.41 | 146,657 | Indirect |
| Mar 31, 2026 | Common Stock | Sale | 87 | US$31.52 | 146,657 | Indirect |
| Apr 1, 2026 | Common Stock | Buy | 1,161 | US$31.53 | 147,731 | Indirect |
| Apr 1, 2026 | Common Stock | Buy | 1,613 | US$34.59 | 147,731 | Indirect |
| Apr 1, 2026 | Common Stock | Buy | 3,401 | US$35.46 | 147,731 | Indirect |
| Apr 1, 2026 | Common Stock | Sale | 1,104 | US$31.52 | 147,731 | Indirect |
| Apr 1, 2026 | Common Stock | Sale | 46 | US$34.75 | 147,731 | Indirect |
Source
Related
- Sensei Biotherapeutics, Inc.
- Millennium Management LLC
- Sensei Biotherapeutics, Inc. shareholders
- Schedule 13G/A · Stempoint Capital LP · Aug 14, 2026
- Schedule 13G · VK Services, LLC · Aug 14, 2026
- Schedule 13G/A · Trails Edge Capital Partners, LP · Aug 14, 2026
- Schedule 13G/A · Caligan Partners LP · Aug 14, 2026
- Schedule 13G · Montanova Capital, LLC · Jun 23, 2026